+ All Categories

Home > Documents > Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Date post:	31-Dec-2015
Category:	Documents
Upload:	darius-maynard
View:	14 times
Download:	1 times

Download Report this document

Share this document with a friend

Description:

Thank you for taking the preassessment. (Note: the questions were developed by an independent consulting group with expertise in assessing the effectiveness of medical education.) To assess learning, these questions will be repeated at the end of the activity. - PowerPoint PPT Presentation

Embed Size (px):

Popular Tags:

bppleiotropic nonbp

mansymplicty global

independent consulting

28

Transcript

Page 1: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 2: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 3: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 4: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 5: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 6: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 7: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 8: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 9: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 10: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 11: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 12: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 13: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 14: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 15: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 16: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 17: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 18: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 19: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 20: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 21: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 22: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 23: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 24: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 25: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 26: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 27: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Page 28: Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Recommended

Symplicity job board

Practical HTN Planning Putting HTN Planning into Use.

Anti Hypertensive. Anti Hypertensive Types of HTN: 1. 1. Alternate HTN. 2. 2. Mild HTN (DBP 91 -104 MMHg). 3. 3. Moderate HTN (DBP 105 -114 MMHg). 4.

The next steps in renal denervation update on Medtronic SPYRAL HTN … · HTN Global Clinical Trial Program is intended to address the confounding factors identified in SYMPLICITY

Renal Denervation in the Most Serious Form of Resistant ... · SYMPLICITY HTN1 and SYMPLICITY HTN- 2 trials, - investigators pinned hopes on RSD as an option in the treatment of hypertension,

SERIES MODEL HTN-31VTCSL5 MODEL HTO-31VTCSL5PAGE 10 — HTN 31V HTN/HTO-31V † RIDE-ON POWER TROWEL — OPERATION AND PARTS MANUAL — REV. #6 (07/09/07) — PAGE 10 HTN/HTO-31V —

The Cardiology Show from ACC 2014 With Dr Valentin Fuster: TAVR, SYMPLICITY HTN …img.medscapestatic.com/.../images/ACC_CardioShow2014.pdf · 2014-04-08 · theheart.org | Medscape

Renal Denervation in Patients with Uncontrolled Hypertension: Results of the SYMPLICITY HTN 3 Trial

Symplicity HTN-1 - OSU Center for Continuing Medical Education

The Cardiology Show from ACC 2014 With Dr Valentin Fuster ...€¦ · The Cardiology Show from ACC 2014 With Dr Valentin Fuster: TAVR, SYMPLICITY HTN-3, and PCSK9 Inhibitors . An

antihypertensive medications: Three-month results … HTN...• Renal denervation therapy (RDN) targets the sympathetic nervous system • SYMPLICITY HTN-3 trial failed to demonstrate

Renal Denervation in Patients with Uncontrolled Hypertension: Results of the SYMPLICITY HTN 3 Trial Deepak L. Bhatt, M.D., M.P.H., David E. Kandzari, M.D.,

OUT OF CRISIS - Symplicity Designs

A Controlled Trial of Renal Denervation for Resistant Hypertension Bhatt DL, Kandzari DE, O’Neill WW et al; SYMPLICITY HTN-3 Investigators SIMPLICITY HTN-3.

Symplicity htn3 acc14

Health & Medicine